Open Orphan Company
A CRO pharma services group which is a world leader in testing of vaccines and antivirals through the use of human challenge clinical trials
Founded Date:
2011-01-01
Funding Status:
IPO
Total Funding:
6300000.0
Employee Number:
1-10
Headquarters:
Dublin, Dublin, Ireland
Last Funding Date:
2020-02-01
Investors Number:
1.0
Last Funding Type:
Post-IPO Equity
Estimated Revenue:
$10M to $50M
Industry:
Clinical Development